Frost & Sullivan releases the 'Market Research Report on Radiofrequency Therapy Devices for Pain Management in China'

Radiofrequency (RF) therapy technology precisely outputs ultra-high frequency radio waves through specialized equipment and puncture needles to act on local tissues, achieving thermal coagulation, cutting, or neural regulation, thereby treating pain disorders. Since pulsed RF technology does not damage nerves and does not cause sensory loss, soreness, burning pain, and motor dysfunction caused by nerve thermal dissociation, and it has significant therapeutic effects, it holds great potential and application value in the treatment of pain disorders. It is a further development and supplement to traditional RF therapy technology. With the continuous increase in the number of pain patients in China, the growing awareness of patient treatment, and the continuous development of the pain discipline, the clinical demand for pain management RF therapy devices in China will continue to expand. Driven by this clinical demand, the market for pain management RF therapy devices in China will also achieve rapid growth. For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released an independent research report titled 'China Pain Management RF Therapy Device Market Research Report'.